BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1469230)

  • 1. [Low grade malignant ovarian carcinomas. A retrospective study of 132 cases].
    Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):761-7. PubMed ID: 1469230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian carcinomas. Retrospective study of 318 cases].
    Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(7):711-6. PubMed ID: 8568178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian tumours: a study of 282 cases.
    Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
    J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium. 118 cases including 13 proliferative and 5 carcinomatous].
    Randrianjafisamindrakotroka NS; Gasser B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):33-8. PubMed ID: 8463564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
    O'Neill CJ; McBride HA; Connolly LE; Deavers MT; Malpica A; McCluggage WG
    Histopathology; 2007 May; 50(6):773-9. PubMed ID: 17493241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases.
    Khunamornpong S; Lerwill MF; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Chiangmai WN; Young RH
    Int J Gynecol Pathol; 2008 Jul; 27(3):366-79. PubMed ID: 18580314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preserving ovarian function in the treatment of epithelial and special (other) malignant ovarian tumors].
    Kolstad P
    Geburtshilfe Frauenheilkd; 1987 Oct; 47(10):683-9. PubMed ID: 2824278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of ovarian tumours among Malaysian women at General Hospital, Kuala Lumpur.
    Thanikasalam K; Ho CM; Adeed N; Shahidan MN; Azizah WK
    Med J Malaysia; 1992 Jun; 47(2):139-46. PubMed ID: 1337368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.